Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
NIVF

Market Cap: $66.96K

NL

NewGenIvf Group Limited

NIVF

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin23.72%

EBITDA Margin3.52%

EBIT Margin3.52%

Pre-tax Margin3.34%

Net Profit Margin3.38%

Earnings Yield132.14%

Valuation Multiples

Price / Book0.00

Price / Sales0.02

Price / Earnings0.01

PEG0.00

Forward PEG0.00

EV / Sales1.54

EV / EBITDA0.44

EV / Operating Cash Flow0.00

EV / Free Cash Flow0.00

Price / Free Cash Flow0.00

Price / Operating Cash Flow0.00

Cash Flow & Capital

Free Cash Flow / Share$0

Operating Cash Flow / Share$0

Free Cash Flow Yield0.00%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.12

Quick Ratio2.98

Cash Ratio0.32

Debt / Assets0.15

Debt / Capital0.15

Debt / Equity0.18

Long-Term Debt / Capital0.13

Debt / Market Cap65.01%

Net Debt / EBITDA0.43

Solvency Ratio1.36

Financial Leverage1.23

Efficiency & Working Capital

Asset Turnover0.08

Fixed Asset Turnover1.18

Inventory Turnover6.16

Receivables Turnover2.53

Payables Turnover2.65

Days Sales Outstanding144.16

Days Inventory Outstanding59.28

Days Payables Outstanding137.76

Operating Cycle203.44

Cash Conversion Cycle65.69

Working Capital Turnover0.60

Returns & Quality

Return on Equity32.69%

Return on Assets27.98%

Return on Invested Capital-24.27%

ROCE-24.66%

Return on Tangible Assets94.60%

Operating Return on Assets-21.93%

Income Quality0.00

Tax Burden1.01

Interest Burden0.95

Balance Sheet & Intrinsic Metrics

Enterprise Value$4.17M

Invested Capital$30.36M

Working Capital$5.02M

Tangible Asset Value$2.94M

Net Current Asset Value$647.5K

Graham Number$1,133.18

Graham Net-Net-$76.62

Book Value / Share$397.6

Tangible Book Value / Share$44.99

Cash / Share$11.61

Financial Health Scores

Piotroski Score5

Altman Z-Score1.71

Revenue$5.45M

EBIT$9.62M

Market Cap$72.02K

Working Capital$5.02M

Retained Earnings$8.89M

Total Assets$32.72M

Total Liabilities$6.74M